You already run a testing operation or sit on a database of blood and lab results — micronutrient panels, biomarker checks, health screenings — but you have no product to sell on top of that data. Novogenia closes the gap. We interpret the relevant blood values, translate them into personalized supplements and manufacture the finished product in our own, certified EU lab — under your brand. You commercialize diagnostic data you already own and open a new revenue stream, without building a manufacturing line.
A database of blood results or a live testing operation is the hard part of personalized nutrition — and it is already sitting with you, unmonetized.
Blood values, micronutrient panels and biomarker data you already produce are interpreted against the relevant markers — no need to start from scratch.
Each result profile is translated into an individual micronutrient formula — the right form and dose per person, not a one-size-fits-all pill.
We produce the finished personalized supplement in our own certified EU lab — from small batches up, Made in Austria — so you sell product, not a build project.
Formula, packaging and fulfillment carry your brand as a white-label solution — Novogenia stays invisible in the background.
The results you already hold become a sellable, reorderable product line — revenue from lab results without a new manufacturing line.
We have run our own certified EU lab since 2009 and offer both genetic and blood analyses — the science behind the product is ours, not outsourced.
We map blood values and micronutrient status to concrete micronutrient recommendations, the basis of a personalized supplement.
Interpretation, formulation, manufacturing, packaging and fulfillment come from a single source, so you generate revenue without building production yourself.
Production to EU requirements in Salzburg — a trust argument you can pass straight to your end customers.
You keep ownership of the lab data and the customer relationship. We are your production partner, not a competitor for your audience.
From a first pilot line to a full personalized range, we grow with you as a long-term manufacturing partner.
Many labs, clinics and health providers generate valuable blood and lab data — micronutrient panels, biomarker checks, health screenings — but have no way to turn it into something people can buy and reorder. That data sits idle. Novogenia is the missing link: we interpret the blood values, translate them into a personalized supplement and manufacture it in our own certified EU lab. You keep the brand, the data and the customer; we deliver the product that turns a results database into a new revenue stream.
Monetize your data →If your company already runs blood analyses or holds a database of lab results — micronutrient panels, biomarker checks, health screenings — you own the expensive, hard-to-build part of personalized nutrition. What is usually missing is a way to monetize that data: to turn results into a product a customer can buy, run out of and reorder. Novogenia specializes in exactly this step. We interpret the relevant blood values, translate them into personalized supplements and manufacture the finished product in our own certified EU lab — so diagnostic data becomes a sellable product line.
The result is a bridge from data to revenue: you keep the lab data, the brand and the customer relationship, while we contribute the biomarker interpretation, the formulation logic and the manufacturing. Instead of building a formulation team and a production line yourself, you plug into an existing, validated infrastructure and open a new revenue stream on data you already own — far faster than building it in-house.
This is built for organizations that already have access to blood or lab data and want to commercialize diagnostic data: blood testing companies and diagnostic labs sitting on a results database, clinics and health-check providers, longevity and preventive-health platforms with biomarker data, corporate-health programs, and brands that already offer blood panels and now want a product to sell on top. If you can supply the results, we can supply the product that generates the revenue.
You do not have to change your testing setup to start earning from it. Where you already hold usable lab results, we can interpret them and move straight to formulation — turning a lab-results database into products without a new operation. Where a fresh analysis is needed, Novogenia also runs blood analyses in its own certified EU lab. Both paths end in the same place: a finished, personalized supplement you sell under your brand.
The value is in the translation from a lab result to a concrete recommendation. Novogenia maps blood values and micronutrient status to specific micronutrient needs — which nutrients a person is likely to require more of, which form is best absorbed, and where a standard supplement would miss. This biomarker-to-formula logic is what lets you generate revenue from biomarker data, converting a set of numbers into an individual product, and it is the same science behind our own personalized product lines.
A new revenue stream only works if production can actually deliver a different formula per person. Novogenia manufactures in its own certified EU lab in Salzburg, from small batches up, so individualized formulations are practical rather than theoretical — and you never build a manufacturing line of your own. On request, active ingredients are delivered through our Microtransporter slow-release technology, which releases nutrients in fast, slow or 50:50 profiles for better tolerance and steadier levels. Everything is produced to EU standard — Made in Austria — which is a strong trust signal to pass on to your end customers.
The entire chain runs as a white-label solution. Formula, packaging, inserts and fulfillment carry your brand; Novogenia never appears to the outside. You own the data and the customer relationship, the new revenue is yours, and we act purely as the production partner in the background — never as a competitor for your audience.
A blood test is done once, but a personalized supplement is consumed and reordered. That is what makes revenue from lab results so attractive for companies that already run lab analyses: the same result can power a recurring, subscription-friendly product line, and a re-test down the line naturally updates the formula. We support fulfillment and reorders so a single analysis becomes lasting revenue rather than a one-time sale.
Depending on your starting point, you may also want to look at turning blood data into supplements, adding follow-up products for blood testing companies or building recurring revenue from blood tests. To discuss your specific data and how to monetize it, get in touch with our team or ask our AI assistant.
Tell us what blood or lab data you hold and what product you want to build on it — we'll come back with a concept for interpretation, formulation and manufacturing under your brand. Or ask our AI assistant directly, around the clock.